1Dalmau J,Gleichman AJ,Hughes EG,et al.Anti-NMDA-receptor encephalitis:case series and analysis of the effects of antibodies.Lancet Neurol,2008,7:1091-1098.
3Lebas A,Husson B,Didelot A,et al.Expanding spectrum of encephalitis with NMDA receptor antibodies in young children.J Child Neurol,2010,25:742-745.
4Ances BM,Vitaliani R,Taylor RA,et al.Treatment-responsive limbic encephalitis identified by neurophil antibodies:MRI and PET correlates.Brain,2005,128:1764-1777.
5Iizuka T,Sakai F,Ide T,et al.Anti-NMDA receptor encephalitis in Japan:long-term outcome without tumor removal.Neurology,2008,70:504-511.
6Ishiura H,Matsuda S,Higashihara M,et al.Response of antiNMDA receptor encephalitis without tumor to immunotherapy including rituximab.Neurology,2008,71:1921-1923.
7Vincent A,Buckley C,Schott JM,et al.Potassium channel antibody-associated encephalopathy:a potentially immunotherapy responsive form of limbic encephalitis.Brain,2004,127:701-712.
8Gultekin SH,Rosenfeld MR,Voltz R,et al.Paraneoplastic limbic encephalitis:neurologic symptoms,immunobiological findings and tumour association in 50 patients.Brain,2000,123:1481-1494.
9Chong JY,Rowland LP,Utiger RD.Hashimoto encephalopathy.Syndrome or myth? Arch Neurol,2003,60:164-171.
